Related Experiment Videos
Levan-induced glomerulitis in rabbits: a possible role for direct complement activation in situ
British Journal of Experimental Pathology
|April 1, 1985
Summary
High-molecular-weight levan unexpectedly worsened experimental glomerulonephritis in rabbits, increasing inflammation and immune deposits. Levan activated complement, likely contributing to these adverse effects in the kidney disease model.
Area of Science:
- Nephrology
- Immunology
- Experimental Pathology
Background:
- High-molecular-weight levan is known to reduce capillary permeability.
- Glomerulonephritis is a kidney disease affecting the glomeruli.
- Acute serum sickness is an experimental model of immune-mediated kidney injury.
Purpose of the Study:
- To investigate if high-molecular-weight levan could attenuate glomerulonephritis in an acute serum sickness model in rabbits.
- To understand the effects of levan on glomerular inflammation and immune complex deposition.
Main Methods:
- Rabbits were induced with acute serum sickness.
- High-molecular-weight levan was administered to assess its effect on glomerulonephritis.
- Kidney tissues and serum complement levels were analyzed.
- In vitro complement activation by levan was studied.
Main Results:
- Levan enhanced glomerular proliferative changes and leucocyte infiltration in rabbits with serum sickness.
- Levan administration alone induced mild glomerulitis and complement C3 deposition.
- Levan activated complement in normal rabbit serum in vitro and in situ.
- Increased IgG deposition was possibly observed in levan-treated rabbits.
Conclusions:
- High-molecular-weight levan exacerbates experimental glomerulonephritis, contrary to expectations.
- Levan-induced complement activation, likely via the alternative pathway, contributes to glomerular inflammation.
- The inflammatory response from levan is additive to classical immune complex-mediated injury in BSA-injected rabbits.